<DOC>
	<DOCNO>NCT01148264</DOCNO>
	<brief_summary>This trial design evaluate olanzapine compare metoclopramide treatment break emesis prophylaxis dexamethasone , 5-HT 3 receptor antagonist aprepitant patient receive chemotherapy . Efficacy assess use modify MASCC questionaire visual analog scale .</brief_summary>
	<brief_title>Comparison Olanzapine Metoclopramide For Treatment Of bReakThrough Emesis</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<mesh_term>Aprepitant</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>break emesis prophylaxis dexamethasone , 5HT 3 receptor antagonist aprepitant patient receive chemotherapy define vomitus nausea &gt; 25mm VAS sign IC psychiatric disorder drug abuse pregnancy high dose chemotherapy treatment antiemetic drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>break-through</keyword>
	<keyword>emesis</keyword>
	<keyword>break emesis prophylaxis dexamethasone , 5-HT 3RA aprepitant</keyword>
</DOC>